BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1052 related articles for article (PubMed ID: 31129359)

  • 21. Host Defense Peptide Mimicking Peptide Polymer Exerting Fast, Broad Spectrum, and Potent Activities toward Clinically Isolated Multidrug-Resistant Bacteria.
    Chen S; Shao X; Xiao X; Dai Y; Wang Y; Xie J; Jiang W; Sun Y; Cong Z; Qiao Z; Zhang H; Liu L; Zhang Q; Zhang W; Zheng L; Yu B; Chen M; Cui W; Fei J; Liu R
    ACS Infect Dis; 2020 Mar; 6(3):479-488. PubMed ID: 31922723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
    Hamouche E; Sarkis DK
    Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats.
    van der Weide H; Cossío U; Gracia R; Te Welscher YM; Ten Kate MT; van der Meijden A; Marradi M; Ritsema JAS; Vermeulen-de Jongh DMC; Storm G; Goessens WHF; Loinaz I; van Nostrum CF; Llop J; Hays JP; Bakker-Woudenberg IAJM
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32540976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and Characterization of Imipenem-Resistant Klebsiella pneumoniae and Susceptible Klebsiella variicola Isolates Obtained from the Same Patient.
    Garza-Ramos U; Moreno-Dominguez S; Hernández-Castro R; Silva-Sanchez J; Barrios H; Reyna-Flores F; Sanchez-Perez A; Carrillo-Casas EM; Sanchez-León MC; Moncada-Barron D
    Microb Drug Resist; 2016 Apr; 22(3):179-84. PubMed ID: 26571390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel antimicrobial peptides identified in legume plant,
    Alhhazmi AA; Alluhibi SS; Alhujaily R; Alenazi ME; Aljohani TL; Al-Jazzar A-AT; Aljabri AD; Albaqami R; Almutairi D; Alhelali LK; Albasri HM; Almutawif YA; Alturkostani MA; Almutairi AZ
    Microbiol Spectr; 2024 Feb; 12(2):e0182723. PubMed ID: 38236024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.
    Pichardo C; Rodríguez-Martínez JM; Pachón-Ibañez ME; Conejo C; Ibáñez-Martínez J; Martínez-Martínez L; Pachón J; Pascual A
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3311-6. PubMed ID: 16048941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioactive metabolites of
    Abdelaziz R; Tartor YH; Barakat AB; El-Didamony G; Gado MM; Berbecea A; Radulov HDI
    Front Cell Infect Microbiol; 2023; 13():1162721. PubMed ID: 37168394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elucidating the anticancer activities of guanidinium-functionalized amphiphilic random copolymers by varying the structure and composition in the hydrophobic monomer.
    Tay J; Zhao Y; Hedrick JL; Yang YY
    Theranostics; 2021; 11(18):8977-8992. PubMed ID: 34522222
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular Characterization of Multidrug-Resistant and Extended-Spectrum Beta-Lactamase-Producing
    Mobasseri G; Teh CSJ; Ooi PT; Tan SC; Thong KL
    Microb Drug Resist; 2019 Sep; 25(7):1087-1098. PubMed ID: 30844323
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.
    Russo A; Giuliano S; Ceccarelli G; Alessandri F; Giordano A; Brunetti G; Venditti M
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control.
    Bassetti M; Righi E; Carnelutti A; Graziano E; Russo A
    Expert Rev Anti Infect Ther; 2018 Oct; 16(10):749-761. PubMed ID: 30207815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.
    Pan CY; Chen JC; Chen TL; Wu JL; Hui CF; Chen JY
    Mar Drugs; 2015 Apr; 13(4):2287-305. PubMed ID: 25874924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates, 2007-2009, China.
    Zhang Y; Yang J; Ye L; Luo Y; Wang W; Zhou W; Cui Z; Han L
    Microb Drug Resist; 2012 Oct; 18(5):465-70. PubMed ID: 22548669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of mortality in acute pancreatitis complicated with multidrug-resistant Klebsiella pneumoniae infection.
    Wu D; Ding J; Jia Y; Liu H; Xiao J; Peng J
    BMC Infect Dis; 2021 Sep; 21(1):977. PubMed ID: 34544384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic and pharmacokinetic profiling of delafloxacin in a murine lung model against community-acquired respiratory tract pathogens.
    Thabit AK; Crandon JL; Nicolau DP
    Int J Antimicrob Agents; 2016 Nov; 48(5):535-541. PubMed ID: 27742208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Hirsch EB; Guo B; Chang KT; Cao H; Ledesma KR; Singh M; Tam VH
    J Infect Dis; 2013 Mar; 207(5):786-93. PubMed ID: 23242537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supernatant of platelet-
    Wang W; Chen Y; Chen Y; Liu E; Li J; An N; Xu J; Gu S; Dang X; Yi J; An Q; Hu X; Yin W
    Microbiol Spectr; 2024 Mar; 12(3):e0127923. PubMed ID: 38289116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High mortality among patients infected with hypervirulent antimicrobial-resistant capsular type K1 Klebsiella pneumoniae strains in Taiwan.
    Lin YT; Cheng YH; Juan CH; Wu PF; Huang YW; Chou SH; Yang TC; Wang FD
    Int J Antimicrob Agents; 2018 Aug; 52(2):251-257. PubMed ID: 29906566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.